Literature DB >> 23541910

Classical cadherins control survival through the gp130/Stat3 axis.

M Geletu1, R Arulanandam, S Chevalier, B Saez, L Larue, H Feracci, L Raptis.   

Abstract

Stat3 (Signal Transducer and Activator of Transcription-3) is activated by a number of receptor and nonreceptor tyrosine kinases. We recently demonstrated that engagement of E-cadherin, a calcium-dependent, cell to cell adhesion molecule which is often required for cells to remain tightly associated within the epithelium, also activates Stat3. We now examined the effect of two other classical cadherins, cadherin-11 and N-cadherin, whose expression often correlates with the epithelial to mesenchymal transition occurring in metastasis of carcinoma cells, upon Stat3 phosphorylation and activity. Our results indicate that engagement of these two cadherins also, can trigger a dramatic surge in Stat3 activity. This activation occurs through upregulation of members of the IL6 family of cytokines, and it is necessary for cell survival, proliferation and migration. Interestingly, our results also demonstrate for the first time that, in sharp contrast to Stat3, the activity of Erk (Extracellular Signal Regulated kinase) was unaffected by cadherin-11 engagement. Further examination indicated that, although IL6 was able to activate Erk in sparsely growing cells, IL6 could not induce an increase in Erk activity levels in densely growing cultures. Most importantly, cadherin-11 knock-down did allow Erk activation by IL6 at high densities, indicating that it is indeed cadherin engagement that prevents Erk activation by IL6. The fact that the three classical cadherins tested so far, E-cadherin, N-cadherin and cadherin11, which are present in essentially all tissues, actually activate Stat3 regardless of their role in metastasis, argues for Stat3 as a central survival, rather than invasion factor.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23541910     DOI: 10.1016/j.bbamcr.2013.03.014

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Effect of caveolin-1 on Stat3-ptyr705 levels in breast and lung carcinoma cells.

Authors:  Mulu Geletu; Zaid Taha; Rozanne Arulanandam; Reva Mohan; Hikmat H Assi; Maria G Castro; Ivan Robert Nabi; Patrick T Gunning; Leda Raptis
Journal:  Biochem Cell Biol       Date:  2019-04-15       Impact factor: 3.626

Review 2.  Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review.

Authors:  Tomas Koltai; Stephan Joel Reshkin; Tiago M A Carvalho; Daria Di Molfetta; Maria Raffaella Greco; Khalid Omer Alfarouk; Rosa Angela Cardone
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

Review 3.  Engaged for survival: From cadherin ligation to STAT3 activation.

Authors:  Mulu Geletu; Stephanie Guy; Rozanne Arulanandam; Hélène Feracci; Leda Raptis
Journal:  JAKSTAT       Date:  2013-12-06

Review 4.  PI3k and Stat3: Oncogenes that are Required for Gap Junctional, Intercellular Communication.

Authors:  Mulu Geletu; Zaid Taha; Patrick T Gunning; Leda Raptis
Journal:  Cancers (Basel)       Date:  2019-02-01       Impact factor: 6.639

Review 5.  Roads to Stat3 Paved with Cadherins.

Authors:  Hanad Adan; Juliet Daniel; Leda Raptis
Journal:  Cells       Date:  2022-08-16       Impact factor: 7.666

6.  CDH11 Regulates Adhesion and Transcellular Migration of Tongue Squamous Cell Carcinoma.

Authors:  Bi-Tan Zheng; Qing-Ling Li; Ting Lan; Jian Xie; You-Guang Lu; Da-Li Zheng; Bo-Hua Su
Journal:  Onco Targets Ther       Date:  2021-07-16       Impact factor: 4.147

Review 7.  Multiple regulation pathways and pivotal biological functions of STAT3 in cancer.

Authors:  Jie Yuan; Fei Zhang; Ruifang Niu
Journal:  Sci Rep       Date:  2015-12-03       Impact factor: 4.379

Review 8.  STAT3, stem cells, cancer stem cells and p63.

Authors:  Michaela Galoczova; Philip Coates; Borivoj Vojtesek
Journal:  Cell Mol Biol Lett       Date:  2018-03-22       Impact factor: 5.787

9.  Tumor cell resistance against targeted therapeutics: the density of cultured glioma tumor cells enhances Stat3 activity and offers protection against the tyrosine kinase inhibitor canertinib.

Authors:  V von Manstein; B Groner
Journal:  Medchemcomm       Date:  2016-10-14       Impact factor: 3.597

Review 10.  The E-Cadherin and N-Cadherin Switch in Epithelial-to-Mesenchymal Transition: Signaling, Therapeutic Implications, and Challenges.

Authors:  Chin-Yap Loh; Jian Yi Chai; Ting Fang Tang; Won Fen Wong; Gautam Sethi; Muthu Kumaraswamy Shanmugam; Pei Pei Chong; Chung Yeng Looi
Journal:  Cells       Date:  2019-09-20       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.